US-Greek Venture gets €32m cash injection
As a result of this designation, the Greek regemed specialist and the US specialist for automated local production of autologous cell therapies will...
Stock market boom: Two biotechs go public
After Evotec’s IPO, two more European companies have gone public: IO Biotech raised US$100m in its IPO on Nasdaq Global Market, selling 7.15 million...
Quell raises US$156m for Treg cell therapy programme
The financing round was co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company...
EC signs prepurchase agreement with Valneva
It’s the 8th contract of the European Commission with a COVID-19 vaccine producer. Under the now signed agreement, Austrian-French (Lyon/Vienna)...
DNA Script bags US$200m financing
Paris and San Francisco-based biotech company DNA Script has completed a Series C financing, raising $200m of new capital. With this latest...
Novartis AG snags Gyroscope for US$1.5bn
The deal includes an upfront cash payment of $800m and up to $700m in cash upon the achievement of certain milestones. Gyroscope’s seed investor and...
Idorsia: Failure in Phase III
The Allschwil-based company announced that in its Phase III study MODIFY, lucerastat did not meet its primary endpoint in patients with Fabry...